There are distinct subtypes of breast cancer: Hormone Receptor positive (HR+), whereby breast tumour growth is responsive to oestrogen or progesterone, and Hormone Receptor negative (HR-), where breast cancer growth is independent of such overactive hormonal signalling. This evidence concerns the gene NR4A1 and breast cancer.